Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- Harmony Outcomes committees and investigators
- Duke University
- GlaxoSmithKline
- Boston University
- University of Toronto
- PAREXEL International
- University of Glasgow
- University of Pisa
Research output: Contribution to journal › Article › peer-review
1595
Scopus
citations